Загрузка...
Interactions of L-dopa and amantadine in patients with Parkinsonism
Twenty-seven patients with Parkinson's disease participated in a double-blind crossover trial of L-dopa and amantadine. Each drug was given for six weeks, and six weeks were allowed to elapse between the two periods of treatment. Marked improvement occurred in patients given L-dopa first, where...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
1973
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC494333/ https://ncbi.nlm.nih.gov/pubmed/4714097 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|